BIOLASE Showcases Breakthrough YSGG Laser Protocol for Predictable Periodontitis Treatment at AAP 2025
BIOLASE (NASDAQ:BIOLQ) will present a new Er,Cr:YSGG YSGG laser resective protocol for treating periodontitis at the American Academy of Periodontology (AAP) 2025 Corporate Forum in Toronto, Oct 15–18.
The featured session by Philip Kang, DDS on Oct 15 at 2:05 PM describes a standardized, minimally invasive approach aiming for predictable pocket elimination, effective bacterial decontamination, and precise osseous contouring. BIOLASE will demonstrate the Waterlase iPlus Premier Edition at Booth #1004 with hands-on demos and giveaways. The release cites a blind McGuire Institute study in the Journal of Periodontology reporting less bleeding/swelling, faster procedures, and superior patient-reported outcomes versus open flap techniques.
BIOLASE (NASDAQ:BIOLQ) presenterà un nuovo protocollo resectivo Er,Cr:YSGG laser YSGG per trattare la parodontite al Corporate Forum 2025 dell'American Academy of Periodontology (AAP) a Toronto, dal 15 al 18 ottobre.
La sessione di rilievo di Philip Kang, DDS, in 15 ottobre alle 14:05 descrive un approccio standardizzato, minimamente invasivo mirato all'eliminazione affidabile delle tasche, alla decontaminazione batterica efficace e alla contourizzazione ossea di precisione. BIOLASE mostrerà il Waterlase iPlus Premier Edition allo stand n. 1004 con dimostrazioni pratiche e omaggi. Il comunicato cita uno studio in cieco del McGuire Institute pubblicato nel Journal of Periodontology che riporta meno sanguinamento/gonfiore, procedure più rapide e migliori esiti riferiti dai pazienti rispetto alle tecniche a lembo aperto.
BIOLASE (NASDAQ:BIOLQ) presentará un nuevo protocolo resectivo Er,Cr:YSGG láser YSGG para tratar la periodontitis en el Corporate Forum 2025 de la American Academy of Periodontology (AAP) en Toronto, del 15 al 18 de octubre.
La sesión destacada por Philip Kang, DDS, el 15 de octubre a las 2:05 PM describe un enfoque estandarizado y mínimamente invasivo que apunta a la eliminación de bolsillos de manera predecible, desinfección bacteriana eficaz y contorneado óseo de precisión. BIOLASE demostrará el Waterlase iPlus Premier Edition en el stand 1004 con demostraciones prácticas y sorteos. El comunicado cita un estudio ciego del McGuire Institute publicado en el Journal of Periodontology que reporta menos sangrado hinchazón, procedimientos más rápidos y resultados informados por los pacientes superiores frente a las técnicas de colgajo abierto.
BIOLASE (나스닥: BIOLQ)가 토론토에서 열리는 American Academy of Periodontology (AAP) 2025 Corporate Forum에서 YSGG 레이저 절제 프로토콜을 신규 Er,Cr:YSGG로 선보일 예정입니다. 10월 15–18일.
Philip Kang DDS가 진행하는 주목받는 세션은 10월 15일 오후 2시 5분에 있으며, 예측 가능한 포켓 제거, 효과적인 세균 박멸, 정밀한 골 형상을 목표로 한 표준화되고 최소 침습적인 접근법을 설명합니다. BIOLASE는 Booth #1004에서 Waterlase iPlus Premier Edition을 시연하고 핸즈온 데모와 경품을 제공합니다. 이 보도 자료는 Journal of Periodontology에 실린 McGuire Institute 연구에서 맹검으로 더 적은 출혈/부기, 더 빠른 시술, 환자 보고 결과가 개방성 절개술(OA) 기술에 비해 우수하다고 보고했습니다.
BIOLASE (NASDAQ:BIOLQ) présentera un nouveau protocole résectif Er,Cr:YSGG làser YSGG pour traiter la parodontite lors du Corporate Forum 2025 de l'American Academy of Periodontology (AAP) à Toronto, du 15 au 18 octobre.
La session phare de Philip Kang, DDS, le 15 octobre à 14h05 décrit une approche standardisée et peu invasive visant à l'élimination prévisible des poches, une décontamination bactérienne efficace et une contourisation osseuse précise. BIOLASE présentera le Waterlase iPlus Premier Edition au stand n°1004 avec des démonstrations pratiques et des cadeaux. Le communiqué cite une étude en aveugle du McGuire Institute publiée dans le Journal of Periodontology montrant moins de saignements / gonflements, des procédures plus rapides et des résultats rapportés par les patients supérieurs par rapport aux techniques de lambeau ouvert.
BIOLASE (NASDAQ:BIOLQ) wird auf dem Corporate Forum 2025 der American Academy of Periodontology (AAP) in Toronto einen neuen Er,Cr:YSGG YSGG-Laserresektionsprotokoll zur Behandlung von Parodontitis vorstellen, vom 15. bis 18. Oktober.
Die vorgestellte Sitzung von Philip Kang, DDS am 15. Oktober um 14:05 Uhr beschreibt einen standardisierten, minimal-invasiven Ansatz mit dem Ziel einer vorhersehbaren Taschenelimination, effektiver bakterieller Dekontamination und präziser osseärer Konturierung. BIOLASE wird den Waterlase iPlus Premier Edition am Stand Nr. 1004 mit praktischen Demos und Giveaways demonstrieren. Die Veröffentlichung nennt eine blinded McGuire Institute-Studie im Journal of Periodontology, die geringere Blutung/Schwellung, schnellere Eingriffe und bessere patientenberichtete Ergebnisse im Vergleich zu offener Lappen-Technik berichtet.
BIOLASE (المدرجة في ناسداك: BIOLQ) ستقدم بروتوكولاً جديداً لليزر Er,Cr:YSGG YSGG لإجراء استئصال لمرضى التهاب اللثة في منتدى الشركات لعام 2025 التابع لأكاديمية أمراض اللثة الأمريكية (AAP) في تورنتو، من 15 إلى 18 أكتوبر.
الجلسة المميزة لفيليـب كانغ، DDS في 15 أكتوبر الساعة 2:05 مساءً تصف نهجاً معيارياً، منخفض التدخل يهدف إلى القضاء المتوقع على الجيوب، التطهير البكتري فعّال وتشكيل عظم دقيق. ستعرض BIOLASE Waterlase iPlus Premier Edition في الجناح 1004 مع عروض تطبيقية وهدايا. تشير النشرة إلى دراسة مخبر McGuire Institute في Journal of Periodontology تفيد بأن هناك نزيف/تورم أقل، إجراءات أسرع، ونتائج يقرّها المرضى بشكل أفضل مقارنة بتقنيات رفع الشفافية المفتوحة.
BIOLASE (纳斯达克股票代码：BIOLQ) 将在多伦多举行的美国牙周病学会（AAP）2025 公司论坛上，推出一种新的 Er,Cr:YSGG YSGG 激光切除协议，用于治疗牙周炎，日期为 10 月 15—18 日。
Philip Kang, DDS 的主打会议于 10 月 15 日 2:05 PM 举行，描述一种标准化、微创的方法，目标是实现可预测的袋间切除、有效的细菌去除以及精确的骨面轮廓塑形。BIOLASE 将在 Booth #1004 展示 Waterlase iPlus Premier Edition，并提供现场演示和赠品。新闻稿引用 McGuire Institute 的盲法研究刊载于《Journal of Periodontology》，相较于开放性翻瓣技术，报道出血/肿胀减少、手术更快、患者自述结果更优。
- None.
- None.
Philip Kang, DDS, will lead a featured session titled "Redefining Periodontitis Treatment: A Novel YSGG Laser-Resective Protocol for Predictable Pocket Elimination" on Wednesday, October 15 at 2:05 PM (Room 709, MTCC).
The presentation introduces an innovative Er,Cr:YSGG laser-assisted surgical protocol designed to standardize resective periodontitis treatment, achieving greater predictability, efficiency, and patient comfort. Attendees will gain insights into how the new technique enables:
- Predictable pocket elimination
- Effective bacterial decontamination
- Precise osseous contouring with minimal invasiveness
This novel protocol leverages YSGG laser technology to deliver consistent, long-term periodontal health—and positions the laser as an essential tool in modern periodontics.
Hands-On Demos and Giveaways at BIOLASE Booth #1004
BIOLASE invites attendees to visit Booth #1004 for live demonstrations of the Waterlase iPlus Premier Edition™, the company's most advanced all-tissue laser. Visitors who test drive the Waterlase iPlus will receive a complimentary BIOLASE travel mug.
The Waterlase iPlus is supported by a landmark blind study designed by The McGuire Institute™ and published in the Journal of Periodontology, confirming:
- Less bleeding, swelling, and postoperative discomfort
- Faster procedures with equivalent results to open flap techniques
- Superior patient-reported outcomes consistent with AAP Best Evidence Consensus recommendations
"BIOLASE is committed to advancing the science and precision of laser dentistry to support better patient care worldwide," said Dr. Kwang Bum Park, CEO of BIOLASE. "Our presence at AAP 2025 demonstrates our continued dedication to innovation that empowers clinicians and transforms treatment outcomes."
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE MG LLC.
For updates and information on BIOLASE and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Instagram at www.instagram.com/biolase_official, and LinkedIn at www.linkedin.com/company/biolase/.
About BIOLASE
BIOLASE is the world's leading innovator in dental laser technology, manufacturing high-performance laser systems that advance dentistry and improve patient experiences. With a legacy of over three decades, BIOLASE continues to define the future of minimally invasive dentistry.
Media Contact
Denise Arterberry
Marketing Manager, BIOLASE
darterberry@biolase.com
949.226.8190
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-showcases-breakthrough-ysgg-laser-protocol-for-predictable-periodontitis-treatment-at-aap-2025-302582930.html
SOURCE BIOLASE MG LLC
FAQ
When will BIOLASE (BIOLQ) present the YSGG laser protocol at AAP 2025?
What will BIOLASE demonstrate at Booth #1004 during AAP 2025?
What are the claimed benefits of the new YSGG protocol announced by BIOLASE (BIOLQ)?
Does BIOLASE cite clinical evidence for the Waterlase iPlus results?
How can investors or clinicians get more information from BIOLASE after AAP 2025?
Will BIOLASE provide hands-on training or materials at AAP 2025 to learn the new protocol?
